trending Market Intelligence /marketintelligence/en/news-insights/trending/jd0IQ-XDJgBZePSZaYCKGg2 content esgSubNav
In This List

Eleven Biotherapeutics receives Nasdaq noncompliance notice

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Eleven Biotherapeutics receives Nasdaq noncompliance notice

Eleven Biotherapeutics Inc. received a notice from the Nasdaq Stock Market LLC for failing to meet the $1 minimum bid price listing requirement.

The company has 180 days or until June 11, 2018, to regain compliance.

To regain compliance, the closing bid price of the company's common stock must meet or exceed $1 per share for a minimum of 10 consecutive business days during the 180-day period.